Response of metastatic breast cancer to trastuzumab?

被引：21

作者：

Barnes, DM ^{[1
]}

Miles, DW

机构：

[1] Guys Hosp, Imperial Canc Res Fund, Breast Pathol Lab, London SE1 9RT, England

[2] Guys Hosp, Imperial Canc Res Fund, Breast Biol Grp, London SE1 9RT, England

来源：

LANCET | 2000年 / 355卷 / 9199期

关键词：

D O I：

10.1016/S0140-6736(99)00430-4

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：160 / 161

页数：2

共 16 条

[1]

Allred DC, 1998, MODERN PATHOL, V11, P155

[2]

Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].

Baselga, J ;

Tripathy, D ;

Mendelsohn, J ;

Baughman, S ;

Benz, CC ;

Dantis, L ;

Sklarin, NT ;

Seidman, AD ;

Hudis, CA ;

Moore, J ;

Rosen, PP ;

Twaddell, T ;

Henderson, IC ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744

[3]

Brenner T L, 1999, J Am Pharm Assoc (Wash), V39, P236

[4]

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease [J].

Cobleigh, MA ;

Vogel, CL ;

Tripathy, D ;

Robert, NJ ;

Scholl, S ;

Fehrenbacher, L ;

Wolter, JM ;

Paton, V ;

Shak, S ;

Lieberman, G ;

Slamon, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2639-2648

[5]

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer [J].

Goldenberg, MM .

CLINICAL THERAPEUTICS, 1999, 21 (02) :309-318

[6]

HANCOCK MC, 1991, CANCER RES, V51, P4575

[7]

MONOCLONAL-ANTIBODIES DIRECTED TO THE ERBB-2 RECEPTOR INHIBIT IN-VIVO TUMOR-CELL GROWTH [J].

HARWERTH, IM ;

WELS, W ;

SCHLEGEL, J ;

MULLER, M ;

HYNES, NE .

BRITISH JOURNAL OF CANCER, 1993, 68 (06) :1140-1145

[8]

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer [J].

Jacobs, TW ;

Gown, AM ;

Yaziji, H ;

Barnes, MJ ;

Schnitt, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :1974-1982

[9]

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the united states food and drug administration-approved scoring system [J].

Jacobs, TW ;

Gown, AM ;

Yaziji, H ;

Barnes, MJ ;

Schnitt, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :1983-1987

[10]

MCKENZIE SJ, 1989, ONCOGENE, V4, P543

← 1 2 →